“The rating action reflects our view of CHS’ substantial and unbudgeted operating losses in unaudited fiscal 2017,” said Suzie Desai, an S&P Global Ratings credit analyst.
The outlook is stable, reflecting S&P’s view of Centegra Health’s turnaround plan, improved market share and demographically favorable service area.
More articles on healthcare finance:
For-profit hospital stock report: Week of Sept. 5-8
Missouri hospital at risk of losing Medicare funding
1 in 6 physician practices pay fees for electronic payments
